Palomino Laboratories (PALX) Notes Payables (2022 - 2025)

Palomino Laboratories has disclosed Notes Payables across 4 years of filings, most recently posting $20000.0 for Q2 2025.

• Notes Payables for Q2 2025 came in at $20000.0, down 81.85% year-over-year; the trailing twelve-month figure through Jun 2025 was $20000.0 (down 81.85% YoY), and the FY2024 annual result was $3140.0, down 68.6% from the prior year.
• Notes Payables came in at $20000.0 for Q2 2025 at Palomino Laboratories, up from $3140.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $130247.0 in Q3 2024 to a low of $304.0 in Q4 2022.
• The 4-year median for Notes Payables is $15625.0 (2024), against an average of $38492.8.
• Across the five-year window, Notes Payables soared 3189.47% in 2023 and tumbled 81.85% in 2025, its largest moves.
• Palomino Laboratories' Notes Payables stood at $304.0 in 2022, then jumped by 3189.47% to $10000.0 in 2023, then sank by 68.6% to $3140.0 in 2024, then surged by 536.94% to $20000.0 in 2025.
• The last three Notes Payables figures came in at $20000.0 (Q2 2025), $3140.0 (Q4 2024), and $130247.0 (Q3 2024), per Business Quant data.